vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and LINKBANCORP, Inc. (LNKB). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $46.0M, roughly 1.4× LINKBANCORP, Inc.). LINKBANCORP, Inc. runs the higher net margin — 6.4% vs -70.9%, a 77.3% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs 7.3%). LINKBANCORP, Inc. produced more free cash flow last quarter ($23.8M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 6.6%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
LINKBANCORP, Inc. is a US-based bank holding company that offers comprehensive retail and commercial banking services to individual consumers, small businesses, and mid-sized enterprises. Its core offerings include deposit accounts, lending products, wealth management solutions, and digital banking services, primarily serving customers across regional markets in Pennsylvania.
CTKB vs LNKB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $46.0M |
| Net Profit | $-44.1M | $2.9M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | 8.5% |
| Net Margin | -70.9% | 6.4% |
| Revenue YoY | 8.1% | 7.3% |
| Net Profit YoY | -557.1% | -61.2% |
| EPS (diluted) | — | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $46.0M | ||
| Q3 25 | $52.3M | $44.8M | ||
| Q2 25 | $45.6M | $42.3M | ||
| Q1 25 | $41.5M | $53.4M | ||
| Q4 24 | $57.5M | $42.9M | ||
| Q3 24 | $51.5M | $42.9M | ||
| Q2 24 | $46.6M | $41.3M | ||
| Q1 24 | $44.9M | $40.5M |
| Q4 25 | $-44.1M | $2.9M | ||
| Q3 25 | $-5.5M | $7.8M | ||
| Q2 25 | $-5.6M | $7.4M | ||
| Q1 25 | $-11.4M | $15.3M | ||
| Q4 24 | $9.6M | $7.6M | ||
| Q3 24 | $941.0K | $7.1M | ||
| Q2 24 | $-10.4M | $5.8M | ||
| Q1 24 | $-6.2M | $5.7M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | 8.5% | ||
| Q3 25 | -17.6% | 22.3% | ||
| Q2 25 | -23.3% | 22.4% | ||
| Q1 25 | -36.1% | 36.0% | ||
| Q4 24 | 5.2% | 22.6% | ||
| Q3 24 | -8.2% | 21.3% | ||
| Q2 24 | -18.3% | 18.0% | ||
| Q1 24 | -23.9% | 18.1% |
| Q4 25 | -70.9% | 6.4% | ||
| Q3 25 | -10.5% | 17.5% | ||
| Q2 25 | -12.2% | 17.5% | ||
| Q1 25 | -27.5% | 28.7% | ||
| Q4 24 | 16.8% | 17.7% | ||
| Q3 24 | 1.8% | 16.5% | ||
| Q2 24 | -22.4% | 14.1% | ||
| Q1 24 | -13.8% | 14.1% |
| Q4 25 | — | $0.08 | ||
| Q3 25 | — | $0.21 | ||
| Q2 25 | — | $0.20 | ||
| Q1 25 | — | $0.41 | ||
| Q4 24 | — | $0.21 | ||
| Q3 24 | — | $0.19 | ||
| Q2 24 | — | $0.16 | ||
| Q1 24 | — | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $52.3M |
| Total DebtLower is stronger | — | $177.3M |
| Stockholders' EquityBook value | $341.7M | $306.4M |
| Total Assets | $461.5M | $3.1B |
| Debt / EquityLower = less leverage | — | 0.58× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $52.3M | ||
| Q3 25 | $93.3M | $194.2M | ||
| Q2 25 | $75.5M | $155.1M | ||
| Q1 25 | $95.3M | $220.2M | ||
| Q4 24 | $98.7M | $166.1M | ||
| Q3 24 | $162.3M | $191.2M | ||
| Q2 24 | $177.9M | $181.7M | ||
| Q1 24 | $168.8M | $172.3M |
| Q4 25 | — | $177.3M | ||
| Q3 25 | — | $102.3M | ||
| Q2 25 | — | $102.3M | ||
| Q1 25 | — | $102.7M | ||
| Q4 24 | — | $112.5M | ||
| Q3 24 | — | $102.4M | ||
| Q2 24 | — | $102.3M | ||
| Q1 24 | — | $102.2M |
| Q4 25 | $341.7M | $306.4M | ||
| Q3 25 | $378.6M | $305.5M | ||
| Q2 25 | $377.6M | $298.0M | ||
| Q1 25 | $379.6M | $294.1M | ||
| Q4 24 | $395.7M | $280.2M | ||
| Q3 24 | $385.5M | $277.4M | ||
| Q2 24 | $389.1M | $271.4M | ||
| Q1 24 | $392.6M | $268.2M |
| Q4 25 | $461.5M | $3.1B | ||
| Q3 25 | $494.9M | $3.1B | ||
| Q2 25 | $493.3M | $2.9B | ||
| Q1 25 | $482.6M | $2.9B | ||
| Q4 24 | $499.5M | $2.9B | ||
| Q3 24 | $491.2M | $2.9B | ||
| Q2 24 | $483.7M | $2.9B | ||
| Q1 24 | $492.1M | $2.8B |
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.33× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.35× | ||
| Q4 24 | — | 0.40× | ||
| Q3 24 | — | 0.37× | ||
| Q2 24 | — | 0.38× | ||
| Q1 24 | — | 0.38× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $25.3M |
| Free Cash FlowOCF − Capex | $-1.8M | $23.8M |
| FCF MarginFCF / Revenue | -2.9% | 51.7% |
| Capex IntensityCapex / Revenue | 1.6% | 3.2% |
| Cash ConversionOCF / Net Profit | — | 8.59× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $55.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $25.3M | ||
| Q3 25 | $-3.9M | $23.6M | ||
| Q2 25 | $108.0K | $6.3M | ||
| Q1 25 | $-125.0K | $2.6M | ||
| Q4 24 | $2.0M | $25.4M | ||
| Q3 24 | $13.2M | $14.0M | ||
| Q2 24 | $6.2M | $6.4M | ||
| Q1 24 | $4.0M | $-771.0K |
| Q4 25 | $-1.8M | $23.8M | ||
| Q3 25 | $-4.6M | $23.2M | ||
| Q2 25 | $-1.5M | $6.1M | ||
| Q1 25 | $-974.0K | $2.2M | ||
| Q4 24 | $1.1M | $22.6M | ||
| Q3 24 | $12.2M | $13.1M | ||
| Q2 24 | $5.2M | $6.3M | ||
| Q1 24 | $3.4M | $-1.2M |
| Q4 25 | -2.9% | 51.7% | ||
| Q3 25 | -8.7% | 51.8% | ||
| Q2 25 | -3.2% | 14.5% | ||
| Q1 25 | -2.3% | 4.2% | ||
| Q4 24 | 1.9% | 52.6% | ||
| Q3 24 | 23.7% | 30.5% | ||
| Q2 24 | 11.0% | 15.3% | ||
| Q1 24 | 7.6% | -3.0% |
| Q4 25 | 1.6% | 3.2% | ||
| Q3 25 | 1.3% | 0.8% | ||
| Q2 25 | 3.5% | 0.4% | ||
| Q1 25 | 2.0% | 0.7% | ||
| Q4 24 | 1.6% | 6.7% | ||
| Q3 24 | 2.0% | 2.1% | ||
| Q2 24 | 2.3% | 0.1% | ||
| Q1 24 | 1.3% | 1.1% |
| Q4 25 | — | 8.59× | ||
| Q3 25 | — | 3.01× | ||
| Q2 25 | — | 0.85× | ||
| Q1 25 | — | 0.17× | ||
| Q4 24 | 0.21× | 3.35× | ||
| Q3 24 | 14.05× | 1.97× | ||
| Q2 24 | — | 1.10× | ||
| Q1 24 | — | -0.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
LNKB
Segment breakdown not available.
